BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11181226)

  • 21. Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma.
    Chunwei F; Weiji W; Xinguan Z; Qingzen N; Xiangmin J; Qingzhen Z
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):209-13. PubMed ID: 12559344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
    Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
    Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
    Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
    Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
    Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
    Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-small cell bronchogenic carcinoma in advanced stages: prognostic value of weight loss and clinical implications].
    Gullón J; Fernández R; Rubinos G; Medina A; Suárez I; González I
    Arch Bronconeumol; 2001 Dec; 37(11):477-81. PubMed ID: 11734136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer.
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Matsuoka H
    Ann Thorac Surg; 1999 Dec; 68(6):2049-52. PubMed ID: 10616975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer.
    Rea F; Loy M; Bortolotti L; Feltracco P; Fiore D; Sartori F
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):201-5. PubMed ID: 9080142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognosis after surgical treatment of spinal metastases due to lung cancer].
    Hessler C; Regelsberger J; Raimund F; Heese O; Madert J; Eggers C
    Chirurg; 2008 Jul; 79(7):671-9. PubMed ID: 18496656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgical therapy of bronchial cancer. Healing or palliation?].
    Erasmi H; Walter M; Krug B; Müller JM; Pichlmaier H
    Zentralbl Chir; 1991; 116(5):295-300. PubMed ID: 1711744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. En bloc resection for lung cancer with chest wall invasion.
    Lin YT; Hsu PK; Hsu HS; Huang CS; Wang LS; Huang BS; Hsu WH; Huang MH
    J Chin Med Assoc; 2006 Apr; 69(4):157-61. PubMed ID: 16689196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in surgical therapy of bronchus carcinoma].
    Ris HB; Eigenmann V; Signer C; Betticher DC; Gugger M; von Briel C
    Ther Umsch; 1998 Jul; 55(7):394-8. PubMed ID: 9702101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of new TNM lung cancer classification.
    Saito Y; Yamakawa Y; Kiriyama M; Fukai I; Kondo S; Yano T; Yokoyama T; Tanahashi M; Nakashima Y; Fujii Y
    Jpn J Thorac Cardiovasc Surg; 2000 Aug; 48(8):499-505. PubMed ID: 11002579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNM staging and long-term follow-up after sleeve resection for bronchogenic tumors.
    Van Schil PE; Brutel de la Rivière A; Knaepen PJ; van Swieten HA; Defauw JJ; van den Bosch JM
    Ann Thorac Surg; 1991 Nov; 52(5):1096-101. PubMed ID: 1953129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma.
    de Perrot M; Licker M; Reymond MA; Robert J; Spiliopoulos A
    Eur Respir J; 1999 Aug; 14(2):419-22. PubMed ID: 10515423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification.
    Jassem J; Skokowski J; Dziadziuszko R; Jassem E; Szymanowska A; Rzyman W; Roszkiewicz A
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1141-6. PubMed ID: 10838530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Actuarial survival and prognostic factors of bronchial cancer].
    Barthlen W; Präuer HW; Hölzel D; Schubert-Fritschle G
    Langenbecks Arch Chir; 1993; 378(1):26-31. PubMed ID: 8437499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.